DK1904529T3 - Anvendelse af Stefin A som et scaffoldprotein - Google Patents

Anvendelse af Stefin A som et scaffoldprotein

Info

Publication number
DK1904529T3
DK1904529T3 DK06744166.7T DK06744166T DK1904529T3 DK 1904529 T3 DK1904529 T3 DK 1904529T3 DK 06744166 T DK06744166 T DK 06744166T DK 1904529 T3 DK1904529 T3 DK 1904529T3
Authority
DK
Denmark
Prior art keywords
stefin
scaffold
scaffold protein
mutations
relates
Prior art date
Application number
DK06744166.7T
Other languages
Danish (da)
English (en)
Inventor
Robbie Woodman
Johannes Tsung-Han Yeh
Sophie Laurenson
Ferrigno Paul Ko
Original Assignee
Medical Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0511873A external-priority patent/GB0511873D0/en
Priority claimed from GB0608836A external-priority patent/GB0608836D0/en
Application filed by Medical Res Council filed Critical Medical Res Council
Application granted granted Critical
Publication of DK1904529T3 publication Critical patent/DK1904529T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1044—Preparation or screening of libraries displayed on scaffold proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK06744166.7T 2005-06-10 2006-06-08 Anvendelse af Stefin A som et scaffoldprotein DK1904529T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0511873A GB0511873D0 (en) 2005-06-10 2005-06-10 Scaffold
GB0608836A GB0608836D0 (en) 2006-05-04 2006-05-04 Scaffold
PCT/GB2006/002115 WO2006131749A2 (en) 2005-06-10 2006-06-08 Scaffold

Publications (1)

Publication Number Publication Date
DK1904529T3 true DK1904529T3 (da) 2010-11-15

Family

ID=37314237

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06744166.7T DK1904529T3 (da) 2005-06-10 2006-06-08 Anvendelse af Stefin A som et scaffoldprotein

Country Status (9)

Country Link
US (2) US8063019B2 (cg-RX-API-DMAC7.html)
EP (1) EP1904529B1 (cg-RX-API-DMAC7.html)
JP (1) JP4989638B2 (cg-RX-API-DMAC7.html)
AT (1) ATE477272T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006256530B2 (cg-RX-API-DMAC7.html)
CA (1) CA2610976C (cg-RX-API-DMAC7.html)
DE (1) DE602006016133D1 (cg-RX-API-DMAC7.html)
DK (1) DK1904529T3 (cg-RX-API-DMAC7.html)
WO (1) WO2006131749A2 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006256530B2 (en) * 2005-06-10 2012-12-20 United Kingdom Research And Innovation Scaffold
GB0807065D0 (en) 2008-04-18 2008-05-21 Univ Leeds Novel scaffolds
GB201302597D0 (en) 2013-02-14 2013-04-03 Univ Leeds Novel Synthetic Proteins
CN106573961B (zh) * 2014-06-20 2022-01-04 豪夫迈·罗氏有限公司 基于chagasin的支架组合物、方法和应用
US20210206818A1 (en) 2016-01-22 2021-07-08 Modernatx, Inc. Messenger ribonucleic acids for the production of intracellular binding polypeptides and methods of use thereof
FI4112741T3 (fi) 2017-01-04 2025-05-15 Mgi Tech Co Ltd Vaiheittainen sekvensointi ei-leimatuilla, reversiibeleillä terminaattoreilla tai luonnollisilla nukleotideilla
US11630106B2 (en) 2017-05-19 2023-04-18 Philip Morris Products S.A. Diagnostic test for distinguishing the smoking status of a subject
GB201710973D0 (en) 2017-07-07 2017-08-23 Avacta Life Sciences Ltd Scaffold proteins
CN114761431B (zh) * 2019-10-16 2025-04-25 株式会社Lg化学 新生儿Fc受体结合AFFIMER
GB202101299D0 (en) 2020-06-09 2021-03-17 Avacta Life Sciences Ltd Diagnostic polypetides and methods
US20230366023A1 (en) 2020-10-09 2023-11-16 Bgi Shenzhen Co., Ltd. Methods and compositions for bioluminescence-based sequencing
WO2023182945A2 (en) * 2022-03-24 2023-09-28 Agency For Science, Technology And Research Engineering peptides using peptide epitope linker evolution
WO2024141788A1 (en) * 2022-12-29 2024-07-04 Affyxell Therapeutics Co., Ltd. Genetically modified stem cells expressing exogenous binding agents and uses thereof
GB202403780D0 (en) 2024-03-15 2024-05-01 Avacta Life Sciences Ltd Polypeptides and methods for detecting and quantifying small molecules

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10510146A (ja) * 1994-11-21 1998-10-06 ザ ユニバーシティ オブ リーズ 改変されたプロテイナーゼインヒビター
EA003637B1 (ru) * 1998-07-20 2003-08-28 Инокселл А/С Новые способы идентификации биомолекул лигандов и мишеней
WO2005046710A2 (en) * 2003-11-06 2005-05-26 Genencor International, Inc. Tgf-beta binding and supported peptides
AU2006256530B2 (en) * 2005-06-10 2012-12-20 United Kingdom Research And Innovation Scaffold

Also Published As

Publication number Publication date
US20080207509A1 (en) 2008-08-28
CA2610976C (en) 2020-11-24
JP2008541776A (ja) 2008-11-27
AU2006256530B2 (en) 2012-12-20
CA2610976A1 (en) 2006-12-14
US8481491B2 (en) 2013-07-09
WO2006131749A3 (en) 2007-05-18
ATE477272T1 (de) 2010-08-15
US8063019B2 (en) 2011-11-22
US20120190819A1 (en) 2012-07-26
WO2006131749A2 (en) 2006-12-14
JP4989638B2 (ja) 2012-08-01
AU2006256530A1 (en) 2006-12-14
DE602006016133D1 (de) 2010-09-23
EP1904529B1 (en) 2010-08-11
EP1904529A2 (en) 2008-04-02

Similar Documents

Publication Publication Date Title
DK2071028T3 (da) HLA-DR-bindende antigenpeptid afledt af WT1
DK1904529T3 (da) Anvendelse af Stefin A som et scaffoldprotein
EA200700136A1 (ru) Анти-cd154-антитела
DK1844150T3 (da) Rekombinant ekspression af proteiner i en to-kædet form med disulfidbroer
DE602005020165D1 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
DE60035419D1 (de) Antigene peptide aus neisseria
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
EA201100070A1 (ru) Туберкулезный белок rv2386c, композиции и их применения
EA201100072A1 (ru) Новые композиции и способы
ATE293169T1 (de) Latency associated peptide von tgf-beta um pharmazeutisch aktive proteine latent zu machen
EA201100071A1 (ru) Новые композиции и способы
ATE457352T1 (de) Subtilisin-carlsberg-proteine mit verminderter immunogenität
DE60335726D1 (de) Chromoprotein und fluoroproteine
ATE323763T1 (de) Dna & protein bindende miniatur proteine
WO2005059131A3 (en) Protein binding miniature proteins and uses thereof
ATE412745T1 (de) Antiangiogene peptide vom n-terminus von endostatin
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
WO2005044845A3 (en) Protein binding miniature proteins
ATE503834T1 (de) Bibliotheken rekombinanter chimärischer proteine
EP1842911A4 (en) HLA BINDING PEPTIDES, FOR THOSE CODING DNA FRAGMENTS AND RECOMBINANT VECTORS
DK1425295T3 (da) Modificerede peptider og deres anvendelse til behandling af autoimmune sygdomme
ATE466876T1 (de) Immunogene konstrukte
EP1757687A4 (en) HLA BINDING PEPTIDE, PRE-STEP, DNA DOMAGING AND RECOMBINANT VECTOR
ATE538806T1 (de) Peptide mit spezifischem sitz in herzgefässen und verwandte konjugate und verfahren
DK2186898T3 (da) Blomstrings-induktion